Strategies for gene therapy
Kaneda, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 12): 486-490
2005
ISSN/ISBN: 0047-1852 PMID: 16416840 Document Number: 587973
Document emailed within 1 workday
Related Documents
Brach, M.A.; Herrmann, F. 1996: Principles and strategies of gene therapy Der Internist 37(4): 343-349Oppenheim, A. 1992: Strategies and challenges in the development of gene therapy Harefuah 122(12): 804-807
Bargon, J.; Buhl, R. 1996: Strategies for gene therapy in cystic fibrosis Pneumologie 50(8): 562-568
Christ, G.J. 2000: Gene therapy: future strategies and therapies Drugs of Today 36(2-3): 175-184
Havlík, R. 2000: Gene therapy strategies for liver tumours Acta Universitatis Palackianae Olomucensis Facultatis Medicae 143: 83
Romero, E.L.; Morilla, M.J.; Bakas, L.S. 2001: Lipid vectors. new strategies for gene therapy Medicina 61(2): 205-214
Portlock, J.L.; Calos, M.P. 2003: Site-specific genomic strategies for gene therapy Current Opinion in Molecular Therapeutics 5(4): 376-382
Bettinger, T.; Read, M.L. 2001: Recent developments in RNA-based strategies for cancer gene therapy Current Opinion in Molecular Therapeutics 3(2): 116-124
Romano, G.; Claudio, P.P.; Kaiser, H.E.; Giordano, A. 1998: Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy In Vivo 12(1): 59-67
Robinson-Benion, C.; Li, Y.X.; Holt, J.T. 1994: Gene transplantation: combined antisense inhibition and gene replacement strategies Leukemia 8(Suppl): S152-S155
Tong, X.W.; Engehausen, D.G.; Kaufman, R.H.; Agoulnik, I.; Contant, C.; Freund, C.T.; Oehler, M.K.; Kim, T.E.; Hasenburg, A.; Woo, S.L.; Kieback, D.G. 1998: Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy Anticancer Research 18(2a): 713-718
Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267
Verma, A.; Maheshwari, M.C. 1992: Current molecular techniques and strategies for gene localization Journal of the Association of Physicians of India 40(6): 405-408
Wang, W.-X.; Dai, K.; Hong, L.; Cai, T.; Tang, L. 2014: The strategies of endosomal escape for intracellular gene delivery Yao Xue Xue Bao 49(8): 1111-1116
Guo, M.-g.; Jiang, M.-h.; Yang, Q.; Li, Y.-m.; Cui, Z.-f.; Li, L.-f.; Wu, M.-c.; Qian, Q.-j. 2004: Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene Zhonghua Yi Xue Za Zhi 84(14): 1147-1151
Bubeník, J.; Zeuthen, J.; Bubeníková, D.; Símová, J.; Jandlová, T. 1993: Gene therapy of cancer: use of IL-2 gene transfer and kinetics of local T and NK cell subsets Anticancer Research 13(5a): 1457-1460
Grgić, M. 2000: Gene therapy of tumors of the head and neck: clinical use of the p53 tumor suppressor gene Lijecnicki Vjesnik 122(1-2): 14-16
Yoon, S.J.; Heo, D.S.; Kang, J.O.; Kim, N.K. 1999: Combination gene therapy of IL-12 and allogeneic MHC class i gene via stimulating NK cytolytic activity Anticancer Research 19(5b): 4337-4342
Cooper, M.J. 1996: Noninfectious gene transfer and expression systems for cancer gene therapy Seminars in Oncology 23(1): 172-187
Bellon, G. 1998: From gene transfer to gene therapy in cystic fibrosis, how long is the road? La Revue du Praticien 48(1): 5-8